SLC26A4 and Parkinson disease: On the contrary, activations of the UPS process could be employed as a therapeutic measure in some diseases, such as for FGF2 in AD and PD, IDE in AD, trafficking-deficient CFTR in cystic fibrosis, and trafficking-deficient pendrin in Pendred syndrome.